Viewing Study NCT02722733

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:55 AM
Ignite Modification Date: 2026-02-26 @ 4:16 PM
Study NCT ID: NCT02722733
Status: UNKNOWN
Last Update Posted: 2016-03-30
First Post: 2016-03-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hodgkin's Lymphoma View
None Non-Hodgkin's Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hodgkin's lymphoma View
None Non-Hodgkin's lymphoma View
None mobilization View
None G-CSF View
None filgrastim View
None cytosine arabinoside View
None autologous stem cell transplantation View